{"id":9907,"date":"2021-03-23T09:16:08","date_gmt":"2021-03-23T14:16:08","guid":{"rendered":"https:\/\/cdtrp.ca\/?p=9907"},"modified":"2021-07-26T12:40:33","modified_gmt":"2021-07-26T17:40:33","slug":"nouveau-financement-felicitations-a-lequipe-cinergy","status":"publish","type":"post","link":"https:\/\/cdtrp.ca\/fr\/nouveau-financement-felicitations-a-lequipe-cinergy\/","title":{"rendered":"Nouveau financement : F\u00e9licitations \u00e0 l&rsquo;\u00e9quipe CINERGY"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1216.8px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-image-element \" style=\"text-align:center;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-dropshadow imageframe-1 hover-type-none\" style=\"-webkit-box-shadow: 3px 3px 7px rgba(0,0,0,0.3);box-shadow: 3px 3px 7px rgba(0,0,0,0.3);\"><img decoding=\"async\" width=\"1024\" height=\"576\" title=\"CINERGY team_FR\" src=\"https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR.png\" data-orig-src=\"https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR-1024x576.png\" alt class=\"lazyload img-responsive wp-image-9970\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271600%27%20height%3D%27900%27%20viewBox%3D%270%200%201600%20900%27%3E%3Crect%20width%3D%271600%27%20height%3D%27900%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR-200x113.png 200w, https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR-400x225.png 400w, https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR-600x338.png 600w, https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR-800x450.png 800w, https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR-1200x675.png 1200w, https:\/\/cdtrp.ca\/wp-content\/uploads\/2021\/03\/CINERGY-team_FR.png 1600w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 1024px) 100vw, (max-width: 640px) 100vw, 1200px\" \/><\/span><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:30px;margin-bottom:30px;width:100%;\"><div class=\"fusion-separator-border sep-double sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;border-bottom-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-1\"><h4>Nouveau financement : F\u00e9licitations \u00e0 l&rsquo;\u00e9quipe CINERGY<\/h4>\n<p>Le PRDTC tient \u00e0 f\u00e9liciter l&rsquo;\u00e9quipe CINERGY, dirig\u00e9e par Fr\u00e9derick D&rsquo;Aragon et Maureen Meade, pour le financement re\u00e7u dans le cadre du concours d&rsquo;automne 2020 des IRSC.<\/p>\n<p>Nous leur avons pos\u00e9 quelques questions sur le processus :<\/p>\n<h5>Comment le PRDTC a-t-il contribu\u00e9 \u00e0 ce travail ?<\/h5>\n<blockquote>\n<p>Le PRDTC soutient l&rsquo;\u00e9tude CINERGY depuis sa cr\u00e9ation. La structure de recherche nationale du PRDTC a fourni des occasions uniques aux chercheurs en don et en transplantation de partout au Canada de connecter entre eux, de faire du remue-m\u00e9ninges et de collaborer \u00e0 la recherche comme jamais auparavant. Les r\u00e9unions r\u00e9guli\u00e8res des Th\u00e8mes permettent un examen scientifique de haut niveau et la participation de cliniciens et de chercheurs chevronn\u00e9s. La force unique du programme de partenariat patient, famille et donneur au sein du PRDTC permet la contribution de ces intervenants cl\u00e9s dans la recherche sur le don et la transplantation en ce qui concerne la conception de l&rsquo;\u00e9tude, les questions \u00e9thiques li\u00e9es au consentement \u00e0 la recherche et les consid\u00e9rations importantes sur les r\u00e9sultats de l&rsquo;\u00e9tude. Le Concours de subventions \u00e0 la recherche et l\u2019innovation du PRDTC a soutenu la recherche qualitative en cours de route afin d&rsquo;am\u00e9liorer la compr\u00e9hension des points de vue des receveurs de greffe en ce qui concerne leur r\u00f4le de participants \u00e0 la recherche clinique impliquant des donneurs d&rsquo;organes. \u00c0 bien des \u00e9gards, le PRDTC a \u00e9t\u00e9 un fervent partisan de l&rsquo;innovation en mati\u00e8re de soins aux donneurs d&rsquo;organes dans l&rsquo;unit\u00e9 de soins intensifs.<\/p>\n<\/blockquote>\n<h5>Comment le PRDTC a-t-il aid\u00e9 \u00e0 la demande de financement ?<\/h5>\n<blockquote>\n<p>Les r\u00e9cents succ\u00e8s de financement n&rsquo;auraient peut-\u00eatre pas \u00e9t\u00e9 possibles sans le soutien sp\u00e9cifique du PRDTC. L&rsquo;\u00e9quipe de gestion a aid\u00e9 \u00e0 pr\u00e9senter ce travail et \u00e0 obtenir des lettres de soutien de presque tous les programmes de transplantation d&rsquo;organes en Ontario et au Qu\u00e9bec. De plus, le PRDTC a fourni sa propre lettre de soutien strat\u00e9gique au projet. Il s&rsquo;est \u00e9galement engag\u00e9 \u00e0 fournir des espaces r\u00e9els et virtuels pour les r\u00e9unions des chercheurs, ainsi qu&rsquo;un soutien financier pour nos patients, familles et donneurs partenaires dans cette aventure passionnante, maintenant financ\u00e9e par les Instituts de recherche en sant\u00e9 du Canada.<\/p>\n<\/blockquote>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:30px;margin-bottom:30px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e0dede;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-2\"><h5 style=\"text-align: justify;\"><strong>R\u00e9sum\u00e9 de l&rsquo;\u00e9tude CINERGY (en anglais)<\/strong><\/h5>\n<p><em>In Canada, most life-saving transplants involve vital organs from deceased organ donors. When organs are removed from organ donors, they are transported with great care to transplant centres in other hospitals, or cities, and even distant provinces. Any interval in time in which a donated organ is preserved without blood circulation may result in organ injury. The time without blood flow can cause organ injury and the re-establishment of blood flow during transplantation may lead to severe injury, called ischemia reperfusion injury, or IR injury. IR injury threatens the viability of organ transplants in the short term, and the long term. Several treatments for transplant recipients aim to reduce the risk of IR injury. Similarly, there are treatments for the organ, itself, before transplant, that aim to mitigate IR injury. There are no treatments, however, provided to organ donors with a view to purpose of reducing IR jury and improving the health of organ transplant recipients. The CINERGY Pilot Trial, in Ontario and Quebec, will test the feasibility of a future national study that tests a drug for administered to organ donors to reduce IR injury in organ recipients. The drug is tacrolimus, a common transplant medication that has never been provided to organ donors. However, animal studies consistently suggest that the \u201cpreconditioning\u201d of organ donors with tacrolimus will improve transplant function.<\/em><\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":6918,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81,37],"tags":[],"class_list":["post-9907","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-vedette","category-non-classifiee"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/9907"}],"collection":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/comments?post=9907"}],"version-history":[{"count":9,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/9907\/revisions"}],"predecessor-version":[{"id":12101,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/9907\/revisions\/12101"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media\/6918"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media?parent=9907"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/categories?post=9907"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/tags?post=9907"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}